株探米国株
日本語 英語
エドガーで原本を確認する
0001489393False00014893932025-04-252025-04-250001489393country:GB2025-04-252025-04-250001489393country:NL2025-04-252025-04-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
 ____________________________________________
FORM 8-K
____________________________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2025
____________________________________________ 
LYONDELLBASELL INDUSTRIES N.V.
(Exact name of registrant as specified in its charter) 
 ____________________________________________ 
Netherlands 001-34726 98-0646235
(State or other jurisdiction
of incorporation)
(Commission
file number)
(I.R.S. Employer
Identification No.)
2800 Post Oak Blvd.,
4th Floor, One Vine Street
Suite 5100 London Delftseplein 27E
Houston, Texas
W1J0AH 3013AA Rotterdam
USA 77056 United Kingdom Netherlands
(Address of principal executive offices) (Zip code)
(713) 309-7200 +44 (0) 207 220 2600 +31 (0) 10 2755 500
(Registrant’s telephone numbers, including area codes) 
(Former name or former address, if changed since last report)
_____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol Name of Each Exchange On Which Registered
Ordinary Shares, €0.04 Par Value LYB New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 2.02.    Results of Operations and Financial Conditions.
On April 25, 2025, LyondellBasell Industries N.V. announced earnings results for the quarter ended March 31, 2025 and provided a supplemental discussion of segment results. Copies of our earnings release and segment results are attached as Exhibit 99.1 and 99.2, respectively, and are incorporated into this Item 2.02 by reference.
The information in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 furnished herewith, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and will not be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.


Item 9.01.     Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1
99.2
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
    LYONDELLBASELL INDUSTRIES N.V.
Date: April 25, 2025  
By: /s/ Matthew D. Hayes
    Matthew D. Hayes
    Senior Vice President,
Chief Accounting Officer
(Principal Accounting Officer)






EX-99.1 2 a2025q1ex991_pressrelease.htm EX-99.1 Document

lyblogoa.jpg
NEWS RELEASE

FOR IMMEDIATE RELEASE
HOUSTON and LONDON, April 25, 2025

LyondellBasell Reports First Quarter 2025 Earnings

•Net income: $177 million, $110 million excluding identified items1
•Diluted earnings per share: $0.54 per share; $0.33 per share excluding identified items
•EBITDA: $655 million, $576 million excluding identified items
•Cash used by operating activities: $579 million
•Returned $543 million to shareholders through dividends and share repurchases
•Prioritized strategic actions on the company's three-pillar strategy:
◦Strengthened U.S. Gulf Coast position with final investment decision to grow propylene production
◦Optimizing global footprint with allocation for cost-advantaged Saudi Arabian feedstocks
◦Upgraded the portfolio by announcing closure of a Dutch PO joint venture and ceasing refinery operations
◦Announcing the 2025 Cash Improvement Plan focused on strengthening financial results by $500 million
LyondellBasell Industries (NYSE: LYB) (the "company") today announced results for the first quarter 2025. Comparisons with the prior quarter and first quarter 2024 are available in the following table:
Table 1 - Earnings Summary
Millions of U.S. dollars (except share data) Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Sales and other operating revenues $7,677 $7,808 $8,304
Net income (loss) 177 (603) 473
Diluted earnings (loss) per share 0.54 (1.87) 1.44
Weighted average diluted share count 324 325 326
EBITDA1
655 (399) 1,046
Excluding Identified Items1
Net income excluding identified items $110 $255 $433
Diluted earnings per share excluding identified items 0.33 0.77 1.31
Gain on sale of business, pre-tax 9
Asset write-downs, pre-tax 1,065
Exit costs, pre-tax 117
(Income) loss from discontinued operations, pre-tax (196) 50 (52)
EBITDA excluding identified items 576 687 963
(1) See “Information Related to Financial Measures” for a discussion of the company’s use of non-GAAP financial measures and Tables 2-5 for reconciliations or calculations of these financial measures. “Identified items” include adjustments for lower of cost or market ("LCM"), gain on sale of business, asset write-downs in excess of $10 million in aggregate for the period, exit costs and discontinued operations.

1


“The LYB team continued to execute well during the first quarter. With planned maintenance at our largest ethylene crackers successfully completed in Europe and the U.S., our assets are well-positioned to serve improving seasonal demand while adapting to dynamic trade flows through a flexible and global manufacturing network. And as we did during the last two years, we continue to take sensible measures to strengthen our near-term cash generation while remaining committed to delivering on our three-pillar strategy through this prolonged industry downturn. Our financial and operational discipline enables us to effectively navigate macroeconomic challenges, achieve sustainable growth and provide a strong and reliable dividend throughout the cycle,” said Peter Vanacker, LyondellBasell chief executive officer.

FIRST QUARTER 2025 RESULTS
The company reported net income for the first quarter 2025 of $177 million, or $0.54 per diluted share. During the quarter, the company recognized identified items of $67 million, net of tax. These items, which impacted first quarter earnings by $0.21 per share, relate to costs incurred from the closure of the Dutch PO joint venture offset by income from discontinued refinery operations. First quarter 2025 EBITDA was $655 million, or $576 million excluding identified items.

In North America, integrated polyethylene profitability was pressured by lower volumes and margins associated with planned and unplanned maintenance at LYB assets as well as sequentially higher ethane and natural gas costs. The company's U.S. polypropylene volumes increased 12% compared to the prior quarter, due to market share gains supported by increased polypropylene operating rates that rose 20 percentage points, reaching 85% of nameplate capacity. In Europe, improved integrated polyethylene profitability was driven by increased ethylene cracker utilization following planned maintenance and typical seasonal demand improvements coupled with modest customer restocking.
Margins in the acetyls and oxyfuels value chains declined as higher natural gas prices impacted costs. The lower ratio of oil-to-gas prices remained a headwind affecting the company's relative feedstock economics across several value chains.
LYB used $579 million in cash from operating activities in the first quarter and exceeded its through-the-cycle cash conversion2 target over the past twelve months. During the first quarter, the company continued to take a balanced approach to capital allocation with $483 million invested in capital expenditures and $543 million returned to shareholders through dividends and share repurchases. First quarter uses of cash included increased receivables and inventories associated with higher volumes following maintenance downtime, the delayed payment of prior year cash taxes and share repurchases. At the end of the quarter, the company held $1.9 billion in cash and cash equivalents and maintained $6.5 billion in available liquidity.

STRATEGY HIGHLIGHTS
LYB continued to navigate dynamic market conditions during the first quarter while advancing on its three-pillar strategy. The company is enhancing its market position by securing an award for a cost-advantaged feedstock allocation in the Middle East and reaching final investment decision to profitably expand its U.S. propylene capacity. To address ongoing macroeconomic volatility, LyondellBasell is announcing a $500 million Cash Improvement Plan focused on strengthening financial results.

(2) Cash conversion is net cash provided by operating activities divided by EBITDA excluding adjustments for lower of cost or market (“LCM”), gain on sale of business and asset write-downs in excess of $10 million in aggregate for the period.
2


OUTLOOK
In the second quarter, the company expects seasonal demand improvements across most businesses. U.S. natural gas and ethane feedstock costs have moderated and operations in Europe and Asia are benefiting from lower crude oil costs. Oxyfuels margins should improve with higher gasoline crack spreads during the summer driving season. In Europe, the rapid pace of capacity rationalization continues and is expected to improve regional supply and demand balances over the coming years. Additionally, more constructive approaches to European economic and regulatory policies are providing measured optimism. Despite economic uncertainty, global packaging demand should remain resilient in serving consumer needs for packaged food, healthcare and other essential everyday products.
To align with global demand and the company's planned maintenance, LYB expects second quarter operating rates of 85% for North American olefins and polyolefins (O&P) assets, 75% for European O&P assets and 85% for Intermediates & Derivatives (I&D) assets.

CONFERENCE CALL
LYB will host a conference call April 25 at 11 a.m. ET. Participants on the call will include Chief Executive Officer Peter Vanacker, Executive Vice President and Chief Financial Officer Agustin Izquierdo, Executive Vice President of Global Olefins and Polyolefins and Refining Kim Foley, Executive Vice President of Intermediates and Derivatives Aaron Ledet, Executive Vice President of Advanced Polymer Solutions Torkel Rhenman and Head of Investor Relations David Kinney. For event access, the toll-free dial-in number is 1-877-407-8029, international dial-in number is 201-689-8029 or click the CallMe link. The slides and webcast that accompany the call will be available at investors.lyondellbasell.com/earnings. A replay of the call will be available from 1:00 p.m. ET April 25 until May 27, 2025. The replay toll-free dial-in numbers are 1-877-660-6853 and 201-612-7415. The access ID for each is 13746205.

ABOUT LYONDELLBASELL
We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating solutions for everyday sustainable living. Through advanced technology and focused investments, we are enabling a circular and low carbon economy. Across all we do, we aim to unlock value for our customers, investors and society. As one of the world's largest producers of polymers and a leader in polyolefin technologies, we develop, manufacture and market high-quality and innovative products for applications ranging from sustainable transportation and food safety to clean water and quality healthcare. For more information, please visit www.LyondellBasell.com or follow @LyondellBasell on LinkedIn.
3


FORWARD-LOOKING STATEMENTS
The statements in this release relating to matters that are not historical facts are forward-looking statements. These forward-looking statements are based upon assumptions of management of LyondellBasell which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. When used in this release, the words “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Actual results could differ materially based on factors including, but not limited to, market conditions, the business cyclicality of the chemical and polymers industries; the availability, cost and price volatility of raw materials and utilities, particularly the cost of oil, natural gas, and associated natural gas liquids; our ability to successfully implement initiatives identified pursuant to our Value Enhancement Program and generate anticipated earnings; competitive product and pricing pressures; labor conditions; our ability to attract and retain key personnel; operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, supplier disruptions, labor shortages, strikes, work stoppages or other labor difficulties, transportation interruptions, spills and releases and other environmental risks); the supply/demand balances for our and our joint ventures’ products, and the related effects of industry production capacities and operating rates; our ability to manage costs; future financial and operating results; our ability to align our assets and grow and upgrade our core, including the results of our strategic review of certain European assets; our ability to reduce our fixed costs and increase cash flow; legal and environmental proceedings; tax rulings, consequences or proceedings; the impacts of tariffs and trade disruptions; technological developments, and our ability to develop new products and process technologies; our ability to meet our sustainability goals, including the ability to operate safely, increase production of recycled and renewable-based polymers to meet our targets and forecasts, and reduce our emissions and achieve net zero emissions by the time set in our goals; our ability to procure energy from renewable sources; our ability to build a profitable Circular & Low Carbon Solutions business; potential governmental regulatory actions; political unrest and terrorist acts; risks and uncertainties posed by international operations, including foreign currency fluctuations; and our ability to comply with debt covenants and to repay our debt. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the “Risk Factors” section of our Form 10-K for the year ended December 31, 2024, which can be found at www.LyondellBasell.com on the Investor Relations page and on the Securities and Exchange Commission’s website at www.sec.gov. There is no assurance that any of the actions, events or results of the forward-looking statements will occur, or if any of them do, what impact they will have on our results of operations or financial condition. Forward-looking statements speak only as of the date they were made and are based on the estimates and opinions of management of LyondellBasell at the time the statements are made. LyondellBasell does not assume any obligation to update forward-looking statements should circumstances or management’s estimates or opinions change, except as required by law.

This release contains time sensitive information that is accurate only as of the date hereof. Information contained in this release is unaudited and is subject to change.

We undertake no obligation to update the information presented herein except as required by law.

INFORMATION RELATED TO FINANCIAL MEASURES
This release makes reference to certain non-GAAP financial measures as defined in Regulation G of the U.S. Securities Exchange Act of 1934, as amended.

4


We report our financial results in accordance with U.S. generally accepted accounting principles, but believe that certain non-GAAP financial measures, such as EBITDA, and EBITDA, net income and diluted EPS exclusive of identified items provide useful supplemental information to investors regarding the underlying business trends and performance of the company's ongoing operations and are useful for period-over-period comparisons of such operations. Non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with GAAP.

We calculate EBITDA as net income (loss) plus interest expense (net), provision for (benefit from) income taxes, and depreciation and amortization. EBITDA should not be considered an alternative to profit or operating profit for any period as an indicator of our performance, or as an alternative to operating cash flows as a measure of our liquidity. We also present EBITDA, net income and diluted EPS exclusive of identified items. Identified items include adjustments for “lower of cost or market" (“LCM”), gain on sale of business, asset write-downs in excess of $10 million in aggregate for the period, exit costs and discontinued operations. Asset write-downs include impairments of goodwill, impairments of long-lived assets, a write-down of a related party loan receivable and a fourth quarter 2024 deferred tax valuation allowance for one of our Chinese joint ventures recognized in Income (loss) from equity investments. Our inventories are stated at the lower of cost or market. Cost is determined using the last-in, first-out (“LIFO”) inventory valuation methodology, which means that the most recently incurred costs are charged to cost of sales and inventories are valued at the earliest acquisition costs. Fluctuation in the prices of crude oil, natural gas and correlated products from period to period may result in the recognition of charges to adjust the value of inventory to the lower of cost or market in periods of falling prices and the reversal of those charges in subsequent interim periods, within the same fiscal year as the charge, as market prices recover. A gain or loss on sale of a business is calculated as the consideration received from the sale less its carrying value. Property, plant and equipment are recorded at historical costs. If it is determined that an asset or asset group’s undiscounted future cash flows will not be sufficient to recover the carrying amount, an impairment charge is recognized to write the asset down to its estimated fair value. Goodwill is tested for impairment annually in the fourth quarter or whenever events or changes in circumstances indicate that the fair value of a reporting unit with goodwill is below its carrying amount. If it is determined that the carrying value of the reporting unit including goodwill exceeds its fair value, an impairment charge is recognized. We assess our equity investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable. If the decline in value is considered to be other than temporary the investment is written down to its estimated fair value. Valuation allowances are provided against deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized. In March 2025, we announced our plans to permanently close our Dutch PO joint venture asset which resulted in the recognition of costs associated with the planned shutdown. In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation.

Cash conversion is a measure commonly used by investors to evaluate liquidity. Cash conversion means net cash provided by operating activities divided by EBITDA excluding LCM, gain on sale of business and asset write-downs in excess of $10 million in aggregate for the period. We believe cash conversion is an important financial metric as it helps management and other parties determine how efficiently the company is converting earnings into cash.

5


These non-GAAP financial measures as presented herein, may not be comparable to similarly titled measures reported by other companies due to differences in the way the measures are calculated. In addition, we include calculations for certain other financial measures to facilitate understanding. This release contains time sensitive information that is accurate only as of the time hereof. Information contained in this release is unaudited and subject to change.
LyondellBasell undertakes no obligation to update the information presented herein except to the extent required by law.

Additional operating and financial information may be found on our website at investors.lyondellbasell.com.

###

Source: LyondellBasell Industries

Media Contact: Monica Silva +1 713-309-7575
Investor Contact: David Kinney +1 713-309-7141

6


Table 2 - Reconciliations of Net Income to Net Income Excluding Identified Items and to EBITDA Including and Excluding Identified Items
Three Months Ended
Millions of U.S. dollars March 31,
2025
December 31,
2024
March 31,
2024
Net income (loss) $ 177  $ (603) $ 473 
Identified items
less: Gain on sale of business, pre-tax(a)
—  — 
add: Asset write-downs, pre-tax(b)
—  1,065  — 
add: Exit costs, pre-tax(c)
117  —  — 
less: (Income) loss from discontinued operations, pre-tax(d)
(196) 50  (52)
add: Provision for (benefit from) income taxes related to identified items 12  (266) 12 
Net income excluding identified items $ 110  $ 255  $ 433 
Net income (loss) $ 177  $ (603) $ 473 
Provision for (benefit from) income taxes 78  (265) 122 
Depreciation and amortization 323  389  365 
Interest expense, net 77  80  86 
EBITDA 655  (399) 1,046 
Identified items
less: Gain on sale of business(a)
—  — 
add: Asset write-down(b)
—  1,065  — 
add: Exit costs(c)
117  —  . — 
less: EBITDA from discontinued operations(d)
(196) 12  (83)
EBITDA excluding identified items $ 576  $ 687  $ 963 
(a) In 2024, we sold our U.S. Gulf Coast-based Ethylene Oxide and Derivatives ("EO&D") business, which resulted in recognition of a gain, including fourth quarter post close adjustments, in our Intermediates & Derivatives ("I&D") segment.
(b) Includes asset write-downs in excess of $10 million in aggregate for the period. The fourth quarter of 2024 reflects non-cash asset write-downs of $1,065 million, which includes a non-cash impairment charge of $837 million related to European assets under strategic review in our Olefins & Polyolefins – Europe, Asia & International ("O&P-EAI") segment, non-cash impairment charges and the recognition of a deferred tax valuation allowance of $52 million and $121 million, respectively, related to a Chinese equity investment in our O&P-EAI segment, and a non-cash impairment charge of $55 million related to our specialty powders business in our Advanced Polymer Solutions ("APS") segment.
(c) In March 2025, we announced plans to shutdown the Dutch PO joint venture asset in our I&D segment, resulting in exit costs of $117 million.
(d) In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation. The related operating results of our refining business are reported as discontinued operations for all periods presented.
Table 3 - Reconciliation of Diluted EPS to Diluted EPS Excluding Identified Items
Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Diluted earnings (loss) per share $ 0.54  $ (1.87) $ 1.44 
Identified items
less: Gain on sale of business —  0.02  — 
add: Asset write-downs(a)
—  2.50  — 
add: Exit costs 0.27  —  — 
less: (Income) loss from discontinued operations (0.48) 0.12  (0.13)
Diluted earnings per share excluding identified items $ 0.33  $ 0.77  $ 1.31 
(a) Includes asset write-downs in excess of $10 million in aggregate for the period.
7


Table 4 - Calculation of Cash and Liquid Investments and Total Liquidity
Millions of U.S. dollars March 31,
2025
Cash and cash equivalents and restricted cash $ 1,870 
Short-term investments — 
Cash and liquid investments 1,870 
add:
Availability under Senior Revolving Credit Facility 3,750 
Availability under U.S. Receivables Facility 900 
Total liquidity $ 6,520 
Table 5 - Calculation of Dividends and Share Repurchases
Three Months
Ended
Millions of U.S. dollars March 31,
2025
Dividends paid - common stock $ 433 
Repurchase of Company ordinary shares 110 
Dividends and share repurchases $ 543 
8
EX-99.2 3 a2025q1ex992_businessresul.htm EX-99.2 Document

lyblogo.jpg
LYONDELLBASELL BUSINESS RESULTS DISCUSSION BY REPORTING SEGMENT
LyondellBasell manages operations through five operating segments: 1) Olefins and Polyolefins-Americas; 2) Olefins and Polyolefins-Europe, Asia and International; 3) Intermediates and Derivatives; 4) Advanced Polymer Solutions; and 5) Technology.

This information should be read in conjunction with our Earnings Release for the period ended March 31, 2025, including the forward-looking statements and information related to financial measures.

Olefins & Polyolefins-Americas (O&P-Americas) - Our O&P-Americas segment produces and markets olefins & co-products, polyethylene and polypropylene.

Table 1 - O&P-Americas Financial Overview
Millions of U.S. dollars Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Operating income $85 $334 $356
EBITDA 251  496  521 


Three months ended March 31, 2025 versus three months ended December 31, 2024 - EBITDA decreased $245 million versus the fourth quarter 2024 largely due to planned and unplanned downtime in the first quarter 2025. Compared to the prior period, olefins results decreased approximately $210 million driven by lower margins due to higher ethane feedstock and natural gas costs coupled with lower co-product contribution as a result of the planned maintenance at the Channelview site. The company's ethylene crackers operated at about 80% of capacity, with the raw materials being approximately 80% ethane and 20% other natural gas liquids. Combined polyolefins results decreased approximately $65 million driven by lower polymer margins due to increased monomer costs. Equity income increased by approximately $5 million.

Three months ended March 31, 2025 versus three months ended March 31, 2024 - EBITDA decreased $270 million versus the first quarter 2024. Olefins results decreased approximately $120 million driven by lower ethylene margins from increased energy costs coupled with lower co-product prices. Combined polyolefin results decreased approximately $140 million due to lower polyethylene margins driven by higher ethylene monomer costs.
1


Olefins & Polyolefins-Europe, Asia, International (O&P-EAI) - Our O&P-EAI segment produces and markets olefins & co-products, polyethylene and polypropylene.

Table 2 - O&P-EAI Financial Overview
Millions of U.S. dollars Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Operating loss $(23) $(1,066) $(11)
EBITDA 17 (1,156) 14
Identified items: Asset write-downs 1,010
EBITDA excluding identified items(a)
17 (146) 14
(a) See "Information Related to Financial Measures" for a discussion of the company's use of non-GAAP financial measures and Table 6 for reconciliations of these financial measures. "Identified items" include adjustments for lower of cost or market ("LCM"), gain on sale of business, asset write-downs in excess of $10 million in aggregate for the period, exit costs and discontinued operations.

Three months ended March 31, 2025 versus three months ended December 31, 2024 - EBITDA increased $1,173 million versus the fourth quarter 2024, or $163 million excluding the impact of asset write-downs of $1,010 million in the fourth quarter 2024. Compared to the prior period, olefins results increased approximately $75 million due to improved cracker margins from higher ethylene prices and lower variable costs and higher olefins volumes from the absence of planned downtime. The company's ethylene crackers operated at approximately 80% of capacity with about 35% of the raw materials derived from non-naphtha feedstocks. Combined polyolefins results increased approximately $55 million compared to the prior period driven by increased margins from higher average sales prices, and higher volumes from seasonality and restocking activities. Joint venture equity income increased by approximately $145 million as the fourth quarter of 2024 was impacted by the recognition of a deferred tax valuation allowance by a Chinese joint venture.

Three months ended March 31, 2025 versus three months ended March 31, 2024 - EBITDA increased $3 million versus the first quarter 2024. Compared to the prior period, olefins results decreased approximately $20 million due to lower margins driven by higher feedstock costs partially offset by higher ethylene prices and lower volumes due to unplanned downtime. Combined polyolefins results decreased approximately $10 million due to higher energy pricing and lower volumes resulting from unplanned downtime. Joint venture equity income increased approximately $25 million due to the absence of losses recognized by a Chinese joint venture.

Intermediates & Derivatives (I&D) - Our I&D segment produces and markets propylene oxide & derivatives, oxyfuels & related products and intermediate chemicals, such as styrene monomer and acetyls.

Table 3 - I&D Financial Overview
Millions of U.S. dollars Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Operating (loss) income $(9) $137 $212
EBITDA 94 241 312
Identified items: Gain on sale of business 9
Identified items: Exit costs 117
EBITDA excluding identified items 211 250 312

2


Three months ended March 31, 2025 versus three months ended December 31, 2024 - EBITDA decreased $147 million compared to the fourth quarter 2024 or $39 million excluding a $9 million adjustment to the gain on sale of our Ethylene Oxide and Derivatives business in the fourth quarter 2024 and shutdown costs of $117 million associated with the Dutch PO joint venture in the first quarter 2025. Compared to the prior period, Propylene Oxide & Derivatives results remained relatively flat as higher PO volumes were partially offset by lower margins. Intermediate Chemicals results decreased approximately $15 million primarily due to higher raw material costs offset slightly by improved styrene margins. Oxyfuels & Related Products results decreased approximately $15 million driven by lower margins on lower blend premiums and lower volumes due to lower demand.

Three months ended March 31, 2025 versus three months ended March 31, 2024 - EBITDA decreased $218 million versus the first quarter 2024 or $101 million excluding shutdown costs of $117 million associated with the Dutch PO joint venture in the first quarter 2025. Compared to the prior period, Propylene Oxide & Derivatives results decreased approximately $25 million due to lower raw material and derivatives margins. Intermediate Chemicals results increased approximately $20 million due to higher volumes and margins with higher methanol pricing and lower feedstock costs coupled with the absence of downtime. Oxyfuels & Related Products results decreased approximately $115 million as margins were significantly compressed on lower gasoline pricing and blend premiums.

Advanced Polymer Solutions (APS) - Our Advanced Polymer Solutions segment produces and markets compounding & solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders.

Table 4 - Advanced Polymer Solutions Financial Overview
Millions of U.S. dollars Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Operating income (loss) $17 $(71) $13
EBITDA 46 (40) 35
Identified items: Asset write-downs 55
EBITDA excluding identified items 46 15 35

Three months ended March 31, 2025 versus three months ended December 31, 2024 - Compared to the fourth quarter 2024, EBITDA increased $86 million or $31 million excluding a $55 million impairment related to the specialty powders business recognized in the fourth quarter 2024. Compared to the prior quarter, EBITDA increased due to higher volumes driven by seasonal demand and increased business wins.

Three months ended March 31, 2025 versus three months ended March 31, 2024 - Compared to the first quarter 2024, EBITDA increased $11 million, driven by higher sales margins and cost efficiency improvement.

Technology - Our Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.

3


Table 5 - Technology Financial Overview
Millions of U.S. dollars Three Months Ended
March 31,
2025
December 31,
2024
March 31,
2024
Operating income $42 $98 $109
EBITDA 52 108 118

Three months ended March 31, 2025 versus three months ended December 31, 2024 - EBITDA decreased $56 million. Prior period results benefited from LIFO inventory valuation changes of approximately $10 million. Compared to the prior period, licensing revenues decreased as the pace of global polyolefins capacity additions moderated partially offset by increased catalyst demand.

Three months ended March 31, 2025 versus three months ended March 31, 2024 - EBITDA decreased $66 million relative to the first quarter 2024. Licensing revenue decreased compared to the prior period on fewer contracts as well as lower catalyst margins and volumes from weaker market sentiment.
4


Capital Spending and Cash Balances
Capital expenditures, including sustaining maintenance and profit-generating growth projects, were $483 million during the first quarter 2025. At the end of the quarter, cash and liquid investment balances were $1.9 billion, which includes cash and cash equivalents, restricted cash and short-term investments. There were 323 million common shares outstanding as of March 31, 2025. The company paid dividends of $433 million and repurchased approximately 1.5 million shares during the first quarter 2025.

INFORMATION RELATED TO FINANCIAL MEASURES
We make reference to certain non-GAAP financial measures as defined in Regulation G of the U.S. Securities Exchange Act of 1934, as amended.

We report our financial results in accordance with U.S. generally accepted accounting principles, but believe that certain non-GAAP financial measures, such as EBITDA exclusive of identified items provides useful supplemental information to investors regarding the underlying business trends and performance of the company's ongoing operations and are useful for period-over-period comparisons of such operations. Non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with GAAP.

We calculate EBITDA as net income (loss) plus interest expense (net), provision for (benefit from) income taxes, and depreciation and amortization. Identified items include adjustments for “lower of cost or market" (“LCM”), gain on sale of business, asset write-downs in excess of $10 million in aggregate for the period, exit costs and discontinued operations. Asset write-downs include impairments of goodwill, impairments of long-lived assets, a write down of a related party loan receivable and a fourth quarter 2024 deferred tax valuation allowance for one of our Chinese joint ventures recognized in Income (loss) from equity investments. Our inventories are stated at the lower of cost or market. Cost is determined using the last-in, first-out (“LIFO”) inventory valuation methodology, which means that the most recently incurred costs are charged to cost of sales and inventories are valued at the earliest acquisition costs. Fluctuation in the prices of crude oil, natural gas and correlated products from period to period may result in the recognition of charges to adjust the value of inventory to the lower of cost or market in periods of falling prices and the reversal of those charges in subsequent interim periods, within the same fiscal year as the charge, as market prices recover. A gain or loss on sale of a business is calculated as the consideration received from the sale less its carrying value. Property, plant and equipment are recorded at historical costs. If it is determined that an asset or asset group’s undiscounted future cash flows will not be sufficient to recover the carrying amount, an impairment charge is recognized to write the asset down to its estimated fair value. Goodwill is tested for impairment annually in the fourth quarter or whenever events or changes in circumstances indicate that the fair value of a reporting unit with goodwill is below its carrying amount. If it is determined that the carrying value of the reporting unit including goodwill exceeds its fair value, an impairment charge is recognized. We assess our equity investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable. If the decline in value is considered to be other than temporary the investment is written down to its estimated fair value. Valuation allowances are provided against deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized. In March 2025, we announced our plans to permanently close our Dutch PO joint venture asset which resulted in the recognition of costs associated with the planned shutdown. In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation.
5


Table 6 - Reconciliation of EBITDA to EBITDA Excluding Identified Items by Segment
Three Months Ended
Millions of U.S. dollars March 31,
2025
December 31,
2024
March 31,
2024
EBITDA:
Olefins & Polyolefins - Americas $ 251  $ 496  $ 521 
Olefins & Polyolefins - EAI 17  (1,156) 14 
Intermediates & Derivatives 94  241  312 
Advanced Polymer Solutions 46  (40) 35 
Technology 52  108  118 
Other, including intersegment eliminations (1) (36) (37)
Discontinued operations 196  (12) 83 
EBITDA $ 655  $ (399) $ 1,046 
Identified items:
less: Gain on sale of business:
Intermediates & Derivatives $ —  $ $ — 
add: Asset write-downs(a):
Olefins & Polyolefins - EAI —  1,010  — 
Advanced Polymer Solutions —  55  — 
add: Exit costs:
Intermediates & Derivatives 117  —  — 
less: Discontinued operations (196) 12  (83)
Total Identified items: $ (79) $ 1,086  $ (83)
EBITDA excluding Identified items:
Olefins & Polyolefins - Americas $ 251  $ 496  $ 521 
Olefins & Polyolefins - EAI 17  (146) 14 
Intermediates & Derivatives 211  250  312 
Advanced Polymer Solutions 46  15  35 
Technology 52  108  118 
Other, including intersegment eliminations (1) (36) (37)
EBITDA excluding Identified items $ 576  $ 687  $ 963 
(a) “Identified items” include adjustments for lower of cost or market (“LCM”), gain on sale of business, asset write-downs in excess of $10 million in aggregate for the period, exit costs and discontinued operations.


6